• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    ICL Reports Fourth Quarter and Full Year 2025 Results

    2/18/26 2:15:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials
    Get the next $ICL alert in real time by email

    Annual sales increase 5% to $7,153 million, with adjusted EBITDA of $1,488 million and earnings per share of $0.36

    Company advances strategic principles, with acquisition of Bartek Ingredients and review of non-core assets

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, consolidated sales of $1,701 million were up 6% versus $1,601 million in the fourth quarter of 2024. Operating income was ($16) million versus $147 million, while adjusted operating income of $223 million was up 17% versus $190 million in 2024. Adjusted EBITDA of $380 million was up 10% versus $347 million in the fourth quarter of 2024. Diluted earnings per share were ($0.06) in the fourth quarter, versus $0.06 in the prior year, while adjusted diluted EPS of $0.09 was up 13% versus $0.08.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217956054/en/

    In the fourth quarter, ICL incurred adjustments totaling $239 million, and the company views these charges as unusual. The adjustments include approximately $122 million for activities related to the execution of ICL's new strategy. These efforts are essential in moving ICL forward and designed to help fund the company's profitable growth engines – specialty crop nutrition and specialty food solutions. These advancements will help the company redirect its resources toward better-aligned opportunities and include the discontinuation of ICL's LFP battery materials projects in St. Louis and in Spain, efficiency improvements at some of our R&D facilities in Israel, and an impairment of assets in the UK. These adjustments also include an $80 million provision for prior years following a Supreme Court ruling regarding water extraction fees in the Dead Sea concession area.

    For the full year, consolidated sales were $7,153 million and up 5% versus $6,841 million in 2024. Operating income was $580 million versus $775 million in 2024, while adjusted operating income was $873 million in both 2025 and 2024. Annual adjusted EBITDA of $1,488 million was up slightly versus $1,469 million in 2024. Diluted earnings per share for 2025 were $0.18 versus $0.32 in 2024, while adjusted diluted EPS was $0.36 versus $0.38. Operating cash flow was $1,056 million in 2025. In 2025, the Company distributed approximately $224 million in dividends to its shareholders.

    "ICL delivered a solid finish to 2025, with fourth quarter sales increasing 6% to $1.7 billion and adjusted EBITDA improving 10% to $380 million. All four of our segments delivered sales growth, with sales for our Industrial Products, Phosphate Solutions and Growing Solutions segments up 4% in the fourth quarter, and we remain committed to growing our leadership position in these segments," said Elad Aharonson, president and CEO of ICL. "Throughout 2025, we benefitted from our distinctive global presence and relied on our regionally diversified operations to expand our specialties solutions offerings to our global customers using local production. This focus helped us to deliver a 5% increase in sales in 2025.

    "This momentum is expected to carry us into 2026, and we are looking forward to executing against our new strategic principles in the coming years. For this year, we expect our two growth engines – specialty crop nutrition, which is part of Growing Solutions, and specialty food solutions, part of our Phosphate Solutions – to help drive improvement, and this will be via M&A, like our recent acquisition of Bartek Ingredients, and as we expand geographically. At the same time, we will stay focused on our core mission of driving profitable growth in all of our specialty businesses, while strengthening our leadership across all business segments.

    "This focus has resulted in a review of our capital allocation priorities and an evaluation of non-synergistic and low-potential activities, including the discontinuation of our downstream expansion into cathode active materials for LFP batteries and a sales review of our Boulby operations in the UK, where we are exploring divestment opportunities. We expect to share updates on our strategic efforts throughout 2026 and look forward to strengthening and growing ICL for the long-term."

    For 2026, the Company expects consolidated adjusted EBITDA to be between $1.4 billion to $1.6 billion. For Potash sales volumes, the company expects between 4.5 million and 4.7 million metric tons in 2026. (1a)

    The international earnings call will begin today at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (289) 819-1520 for international analysts, and the conference ID is 71097. Employees, the media and the public are invited to listen to the call using the webcast link found at ICL Group Investors Relations - Reports News & Events.

    Financial Figures and non-GAAP Financial Measures

    10-12/2025

    10-12/2024

    1-12/2025

    1-12/2024

     

    $

    millions

    % of

    Sales

    $

    millions

    % of

    Sales

    $

    millions

    % of

    Sales

    $

    millions

    % of

    Sales

    Sales

    1,701

    -

    1,601

    -

    7,153

    -

    6,841

    -

    Gross profit

    468

    28

    535

    33

    2,186

    31

    2,256

    33

    Operating income (loss)

    (16)

    (1)

    147

    9

    580

    8

    775

    11

    Adjusted operating income (1)

    223

    13

    190

    12

    873

    12

    873

    13

    Net income (loss) attributable to the Company's shareholders

    (73)

    (4)

    70

    4

    226

    3

    407

    6

    Adjusted net income attributable to the Company's shareholders (1)

    121

    7

    104

    6

    465

    7

    484

    7

    Diluted earnings per share (in dollars)

    (0.06)

    -

    0.06

    -

    0.18

    -

    0.32

    -

    Diluted adjusted earnings per share (in dollars) (2)

    0.09

    -

    0.08

    -

    0.36

    -

    0.38

    -

    Adjusted EBITDA (2)

    380

    22

    347

    22

    1,488

    21

    1,469

    21

    Cash flows from operating activities (3)

    314

    -

    452

    -

    1,056

    -

    1,468

    -

    Purchases of property, plant and equipment and intangible assets (3)

    252

    -

    267

    -

    824

    -

    713

    -

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" below.

    (2)

    See "Adjusted EBITDA and Diluted Adjusted Earnings Per Share for the periods of activity" below.

    (3)

    See "Condensed consolidated statements of cash flows (unaudited)" in the appendix below.

     
     

    Segment Information

    Industrial Products

    The Industrial Products segment produces bromine from a highly concentrated solution in the Dead Sea and bromine‑based compounds at its facilities in Israel, the Netherlands and China. In addition, the segment produces several grades of salts, magnesium chloride, magnesia-based products, phosphorus-based products and functional fluids.

    Results of operations and key indicators

     

    10-12/2025

    10-12/2024

    1-12/2025

    1-12/2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Segment Sales

    296

    280

    1,254

    1,239

    Sales to external customers

    294

    275

    1,238

    1,220

    Sales to internal customers

    2

    5

    16

    19

    Segment Operating Income

    52

    55

    220

    224

    Depreciation and amortization

    16

    15

    60

    57

    Segment EBITDA

    68

    70

    280

    281

    Capital expenditures

    28

    38

    81

    94

    Significant highlights for the fourth quarter

    • Flame retardants: Sales of bromine-based products remained flat year-over-year, as higher prices were offset by lower volumes due to continued weak demand. Sales of phosphorus-based products were also flat year-over-year, driven mainly by lower volumes in Europe, offset by higher volumes and prices in the US following duties on imports of tris (2-chloro-1-methylethyl) phosphate (TCPP) from China.
    • Elemental bromine: Sales increased year-over-year, as higher prices offset lower volumes.
    • Clear brine fluids: Sales increased year-over-year, driven by higher demand in South America and Europe.
    • Specialty minerals: Sales increased year-over-year, driven by higher demand for magnesium chloride for deicing in the US following an early snowfall, which resulted in strong pre-season sales. This was partially offset by lower sales in certain industrial applications.

    Results analysis for the period October – December 2025

     

    Sales

    Expenses

    Operating income

     

    $ millions

    Q4 2024 figures

    280

    (225)

    55

    Quantity

    (13)

    10

    (3)

    Price

    24

    -

    24

    Exchange rates

    5

    (13)

    (8)

    Raw materials

    -

    1

    1

    Energy

    -

    (1)

    (1)

    Transportation

    -

    4

    4

    Operating and other expenses

    -

    (20)

    (20)

    Q4 2025 figures

    296

    (244)

    52

     
    • Quantity – The negative impact on operating income was primarily due to lower sales volumes of bromine-based flame retardants and phosphorus-based industrial solutions, partially offset by higher sales volumes of clear brine fluids.
    • Price – The positive impact on operating income was primarily due to higher selling prices of bromine-based industrial solutions, bromine-based flame retardants, specialty minerals, and phosphorus- based flame retardants.
    • Exchange rates – The unfavorable impact on operating income was mainly driven by higher operational costs due to the appreciation of the average exchange rate of the Israeli shekel against the US dollar, which outweighed the positive impact on sales from the euro's appreciation.
    • Operating and other expenses – The negative impact on operating income was mainly related to higher operational costs.

    Potash

    The Potash segment produces and sells mainly potash, salts, magnesium and electricity. Potash is produced in Israel using an evaporation process to extract potash from the Dead Sea at Sodom and in Spain using conventional mining from an underground mine. The segment also produces and sells pure magnesium, magnesium alloys and chlorine. In addition, the segment sells salt products produced at its potash site in Spain. The segment operates a power plant in Sodom, which supplies electricity and steam to ICL facilities in Israel with any surplus electricity sold to external customers.

    Results of operations and key indicators

     

    10-12/2025

    10-12/2024

    1-12/2025

    1-12/2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Segment Sales

    473

    422

    1,714

    1,656

    Potash sales to external customers

    370

    315

    1,308

    1,237

    Potash sales to internal customers

    27

    30

    89

    95

    Other and eliminations (1)

    76

    77

    317

    324

    Gross Profit

    163

    61

    622

    650

    Segment Operating Income

    86

    69

    298

    250

    Depreciation and amortization

    64

    61

    254

    242

    Segment EBITDA

    150

    130

    552

    492

    Capital expenditures

    124

    116

    367

    332

    Potash price - CIF ($ per tonne)

    348

    285

    316

    299

    (1)

    Primarily includes salt produced in Spain, metal magnesium-based products, chlorine and sales of surplus electricity produced by ICL's power plant at the Dead Sea in Israel.

     
     

    Significant highlights for the fourth quarter

    • ICL's potash price (CIF) per tonne was $348 in the fourth quarter, reflecting a 22% increase year-over-year.
    • The Grain Price Index declined by 4.4% in the fourth quarter. While corn, wheat, and soy increased quarter-over-quarter by 2.6%, 0.1%, and 5.1%, respectively, rice declined by 15.7% due to expectations of global oversupply. On a year-over-year basis, the Index declined by 13.9%, as corn and soy increased by 0.6% and 8.6%, respectively, while wheat and rice decreased by 10.7% and 31.1%, respectively.
    • The WASDE (World Agricultural Supply and Demand Estimates) report, published by the USDA in January 2026, showed a continued decrease in the expected ratio of global inventories of grains to consumption to 26.7% for the 2025/26 agriculture year, compared to 26.9% for the 2024/25 agriculture year, and 28.3% for the 2023/24 agriculture year.
    • In December 2025, under ICL's 2025–2027 Chinese framework agreements, the Company signed contracts with its Chinese customers to supply 750,000 tonnes of potash, with a mutual option for an additional 330,000 tonnes, to be supplied during 2026 at a price of $348 per tonne. This rate was in line with recent industry contract settlements.
    • Metal Magnesium: Sales decreased year-over-year due to lower sales volumes.

    Additional segment information

    Global potash market - average prices and imports:

    Average prices

     

    10-12/2025

    10-12/2024

    VS Q4 2024

    7-9/2025

    VS Q3 2025

    Granular potash – Brazil

    CFR spot

    ($ per tonne)

    355

    288

    23.3%

    360

    (1.4)%

    Granular potash – Northwest Europe

    CIF spot/contract

    (€ per tonne)

    365

    338

    8.0%

    365

    0.0%

    Standard potash – Southeast Asia

    CFR spot

    ($ per tonne)

    373

    292

    27.7%

    370

    0.8%

    Potash imports

     

     

     

     

     

     

    To Brazil

    million tonnes

    2.5

    2.9

    (13.8)%

    4.0

    (37.5)%

    To China

    million tonnes

    4.0

    3.4

    17.6%

    2.4

    66.7%

    To India

    million tonnes

    1.0

    1.2

    (16.7)%

    0.9

    11.1%

     

    Sources: CRU (Fertilizer Week Historical Price: December 2025), SIACESP (Brazil), United Port Services (Brazil), FAI (India), Chinese customs data, Global Trade Tracker (GTT).

     
     

    Potash – Production and Sales

    Thousands of tonnes

    10-12/2025

    10-12/2024

    1-12/2025

    1-12/2024

    Production

    1,222

    1,178

    4,377

    4,502

    Total sales (including internal sales)

    1,200

    1,259

    4,320

    4,556

    Closing inventory

    286

    229

    286

    229

     

    Fourth quarter 2025

    • Production – Production was 44 thousand tonnes higher year-over-year, mainly due to a planned production shutdown at our Spanish plant in Q4 2024 that reduced production in that period.
    • Sales - The quantity of potash sold decreased by 59 thousand tonnes year-over-year due to adverse weather conditions toward year-end that disrupted loading operations at Ashdod Port and led to lower sales volumes mainly in the US and Europe.

    Full year 2025

    • Production – Production was 125 thousand tonnes lower year-over-year, mainly due to operational challenges.
    • Sales – The quantity of potash sold was 236 thousand tonnes lower year-over-year, mainly due to lower production in the first half of the year and adverse weather conditions toward year-end that disrupted loading operations at Ashdod Port, leading to reduced sales volumes primarily in the US and South America.

    Results analysis for the period October – December 2025

     

    Sales

    Expenses

    Operating income

     

    $ millions

    Q4 2024 figures

    422

    (353)

    69

    Quantity

    (11)

    1

    (10)

    Price

    55

    -

    55

    Exchange rates

    7

    (13)

    (6)

    Raw materials

    -

    2

    2

    Energy

    -

    (6)

    (6)

    Transportation

    -

    (1)

    (1)

    Operating and other expenses

    -

    (17)

    (17)

    Q4 2025 figures

    473

    (387)

    86

    • Quantity – The negative impact on operating income was primarily due to lower potash sales volumes in the US and Europe, as well as decreased sales volumes of magnesium. This was partially offset by higher potash sales volumes in China, India and Brazil.
    • Price – The positive impact on operating income was primarily driven by a $63 year-over-year increase in the potash price (CIF) per tonne.
    • Exchange rates – The unfavorable impact on operating income was mainly due to higher operational costs resulting from the appreciation of the average exchange rate of the euro and the Israeli shekel against the US dollar, which outweighed their positive impact on sales.
    • Energy – The negative impact on operating income was primarily driven by higher water fees and electricity prices.
    • Operating and other expenses – The negative impact on operating income was primarily related to higher maintenance and operational costs, as well as higher royalty payments.

    Phosphate Solutions

    The Phosphate Solutions segment operates ICL's phosphate value chain and uses phosphate rock and fertilizer-grade phosphoric acid to produce phosphate-based specialty products with higher added value, as well as to produce and sell phosphate-based fertilizers.

    Results of operations and key indicators

     

    10-12/2025 (1)

    10-12/2024

    1-12/2025 (2)

    1-12/2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Segment Sales

    518

    507

    2,333

    2,215

    Sales to external customers

    471

    475

    2,156

    2,049

    Sales to internal customers

    47

    32

    177

    166

    Segment Operating Income

    76

    81

    342

    358

    Depreciation and amortization

    45

    51

    186

    191

    Segment EBITDA

    121

    132

    528

    549

    Capital expenditures

    94

    147

    336

    340

    (1)

    For Q4 2025, Phosphate Specialties accounted for $ 324 million of segment sales, $ 41 million of operating income, $ 12 million of D&A and $ 53 million of EBITDA, while Phosphate Commodities accounted for $ 194 million of segment sales, $ 35 million of operating income, $ 33 million of D&A and represented $ 68 million of EBITDA.

    (2)

    For 2025, Phosphate Specialties accounted for $1,332 million of segment sales, $157 million of operating income, $49 million of D&A and $206 million of EBITDA, while Phosphate Commodities accounted for $1,001 million of segment sales, $185 million of operating income, $137 million of D&A and $322 million of EBITDA.

     

    Significant highlights for the fourth quarter

    • Commodity phosphate prices declined in Q4 2025, driven by seasonal slowdowns, high input costs, and mounting affordability concerns that triggered significant regional market shifts.
      • In China, the phosphate export window closed in October 2025. Weak demand and poor sentiment pushed DAP FOB prices down $88/mt from September to December, while a severe sulphur shortage raised production costs, lifting domestic DAP prices by ~$32/mt (RMB225/mt) and leading to tighter, longer export restrictions for 2026.
      • In the US, DAP FOB NOLA fell $209/mt from an August 2025 peak of $887/mt, mainly in Q4, driven by weak demand, affordability concerns, and sector uncertainty. Through September, DAP and MAP imports were down 41% year-over-year and 31% below the five-year average, with market dynamics further shaped by a Senate investigation and the removal of most fertilizer tariffs in November.
      • In Brazil, Q4 phosphate prices softened, with MAP CFR falling from $760/mt in July to $630/mt by December 2025, as high prices and weak affordability weighed on consumption. Through November, DAP and MAP imports were well below the five-year average, partially offset by rising TSP and SSP imports as buyers sought cheaper alternatives.
    • Indian phosphoric acid prices, negotiated quarterly, rose $32/mt to $1,290/mt P₂O₅ in Q4 2025. Q1 2026 prices are still under negotiation.
    • Sulphur FOB Middle East ended the fourth quarter at $515/mt, up $188/mt quarter-over-quarter. This increase was driven by strong demand from the metals sector in Southeast Asia and the phosphate sector in China, and by tight availability, particularly from Russia and other countries in the former Soviet Union.
    • The broader functional food ingredients market—valued at approximately $35 billion—is demonstrating strong growth, with a CAGR of 5% to 6%, fueled by global mega trends such as food security, health & lifestyle and dietary shifts towards protein enrichment.
    • The industrial segment is being reshaped by the global energy transition, specifically the growth of Lithium Iron Phosphate (LFP) batteries, which is accelerating demand of purified phosphoric acid. This trend is most pronounced in China, which remains the global epicenter for LFP cathode production.
    • White phosphoric acid (WPA): Sales increased year-over-year, driven mainly by higher volumes and prices, particularly in Asia. Sales of food grade white phosphoric acid (WPA FG) slightly decreased year-over-year, due to a shift in Chinese volumes toward products used in batteries.
    • Sales of battery materials in China increased year-over-year, driven by higher volumes and prices and as the Company expanded its business in response to increased industry demand.



      As part of the Company's strategic portfolio optimization efforts, ICL has shifted its approach to LFP battery materials. While the Company will continue supplying raw materials to battery customers, it will not move further downstream into cathode active materials. Accordingly, it discontinued its previously announced projects in St. Louis and Spain, following a review of shifting market dynamics and recent changes in government policies.
    • Industrial salts: Sales increased slightly year-over-year, driven by higher prices in Europe.
    • Food specialties: Sales slightly increased versus the previous year and reflected growing volumes in North America and Asia, as part of the Company's regional expansion strategy.



      In January 2026, the Company acquired 49.9% of Bartek Ingredients' shares, a global leader in food-grade malic and fumaric acids, serving hundreds of customers and distributors across the food, beverage, confectionery, bakery and other end-markets worldwide. These functional food ingredients are used by food and beverage companies to enhance flavour profiles, extend shelf life, and improve overall product quality.

    Additional segment information

    Global Phosphate Commodities market - average prices per tonne:

     

     

    10-12/2025

    10-12/2024

    VS Q4 2024

    7-9/2025

    VS Q3 2025

    DAP

    CFR India Bulk Spot

    721

    637

    13%

    807

    (11)%

    TSP

    CFR Brazil Bulk Spot

    558

    500

    12%

    603

    (7)%

    SSP

    CPT Brazil inland 18-20% P2O5 Bulk Spot

    287

    270

    6%

    303

    (5)%

    Sulphur

    Bulk FOB Adnoc monthly Bulk contract

    394

    139

    183%

    271

    45%

     

    Source: CRU (Fertilizer Week Historical Prices, December 2025).

     

    Results analysis for the period October – December 2025

     

    Sales

    Expenses

    Operating income

     

    $ millions

    Q4 2024 figures

    507

    (426)

    81

    Quantity

    (21)

    16

    (5)

    Price

    23

    -

    23

    Exchange rates

    9

    (13)

    (4)

    Raw materials

    -

    (36)

    (36)

    Energy

    -

    1

    1

    Transportation

    -

    (1)

    (1)

    Operating and other expenses

    -

    17

    17

    Q4 2025 figures

    518

    (442)

    76

    • Quantity – The negative impact on operating income was primarily due to lower sales volumes of phosphate fertilizers, partially offset by higher sales volumes of white phosphoric acid (WPA), phosphate-based food additives, and of MAP used as a raw material for energy storage solutions.
    • Price – The positive impact on operating income was primarily due to higher selling prices of phosphate fertilizers and salts, partially offset by lower selling prices of phosphate-based food additives.
    • Exchange rates - The unfavorable impact on operating income was mainly due to higher operational costs resulting from the appreciation of the average exchange rate of the euro, Chinese yuan and the Israeli shekel against the US dollar, partially offset by higher sales driven primarily by stronger euro and yuan.
    • Raw materials – The negative impact on operating income was primarily due to higher sulphur costs.
    • Operating and other expenses – The positive impact on operating income was primarily related to lower operational expenses.

    Growing Solutions

    The Growing Solutions segment aims to achieve global leadership in plant nutrition by enhancing its position in its core markets of agriculture, ornamental horticulture, turf and landscaping, and by targeting high-growth markets such as Brazil, India, and China. The segment leverages its unique R&D capabilities, substantial agronomic experience, global footprint, backward integration into potash, phosphate and polysulphate and its chemistry know-how, as well as its ability to integrate and generate synergies from acquired businesses. The segment continuously works to expand its broad portfolio of specialty plant nutrition, plant stimulation and plant health solutions, which consists of enhanced efficiency and controlled release fertilizers (CRF), water-soluble fertilizers (WSF), liquid fertilizers, straights (MKP/MAP/PeKacid), FertilizerpluS, soil and foliar micronutrients, biostimulants, soil conditioners, seed treatment products and adjuvants.

    Results of operations and key indicators

     

    10-12/2025

    10-12/2024

    1-12/2025

    1-12/2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Segment Sales

    467

    439

    2,063

    1,950

    Sales to external customers

    465

    435

    2,048

    1,932

    Sales to internal customers

    2

    4

    15

    18

    Segment Operating Income

    41

    31

    135

    128

    Depreciation and amortization

    19

    20

    78

    74

    Segment EBITDA

    60

    51

    213

    202

    Capital expenditures

    41

    44

    95

    98

     
     

    Significant highlights for the fourth quarter

    Regional highlights:

    • Brazil: Sales increased year-over-year, mainly due to higher prices and exchange rate fluctuations, resulting in strong gross profit.
    • Europe: Sales increased year-over-year, as higher selling prices and exchange rate fluctuations offset lower sales volumes. Improved pricing and products mix partially offset higher raw materials costs and drove higher gross profit.
    • North America: Sales decreased year-over-year due to lower volumes, while improved pricing and product mix supported higher gross profit.
    • Asia: Sales increased year-over-year mainly due to higher volumes, while elevated raw material costs pressured gross profit.

    Product highlights:

    • Specialty Agriculture (SA): Sales increased year-over-year, due to higher prices mainly for CRF, micronutrients and biostimulants in Brazil, as well as favorable exchange rate fluctuations for the Brazilian real and euro. This was partially offset by lower sales volumes, mainly in Brazil and Europe.
    • Turf and Ornamental (T&O): Sales increased year-over-year, driven by higher sales volumes mainly CRF in Europe, as well as favorable exchange rate fluctuations of the euro.
    • FertilizerpluS: Sales increased year-over-year, due to higher prices, mainly PK plus and potash pluS in Europe, together with favorable euro exchange rate movements.

    Results analysis for the period October – December 2025

     

    Sales

    Expenses

    Operating income

     

    $ millions

    Q4 2024 figures

    439

    (408)

    31

    Quantity

    (9)

    9

    -

    Price

    10

    -

    10

    Exchange rates

    27

    (25)

    2

    Raw materials

    -

    (14)

    (14)

    Energy

    -

    3

    3

    Transportation

    -

    1

    1

    Operating and other expenses

    -

    8

    8

    Q4 2025 figures

    467

    (426)

    41

    • Quantity – The impact on operating income was neutral, mainly as lower sales volumes of FertilizerpluS products offset higher sales volumes of turf and ornamental products.
    • Price – The positive impact on operating income was due to higher selling prices of specialty agriculture and FertilizerpluS products. This impact was partially offset by lower prices of turf and ornamental products.
    • Exchange rates – The favorable impact on operating income was mainly due to higher sales resulting from the appreciation of the Brazilian real and euro against the US dollar, which outweighed their negative impact on operational costs.
    • Raw materials – The negative impact on operating income was primarily related to higher costs of sulphur, commodity fertilizers, and nitrogen.
    • Operating and other expenses – The positive impact on operating income was primarily related to lower operational costs.

    Financing expenses, net

    Net financing expenses in the fourth quarter of 2025 totaled $45 million, compared to $33 million in the corresponding quarter last year, reflecting an increase of $12 million.

    Tax expenses

    In the fourth quarter of 2025, the Company's reported tax expenses amounted to $2 million, compared to $33 million in the corresponding quarter of last year, reflecting an effective tax rate of 3% and 29%, respectively. Adjusted tax expenses totaled $47 million, compared to $42 million in the corresponding period of last year, reflecting an effective tax rate of 26% and 27%, respectively.

    Liquidity and Capital Resources

    As of December 31, 2025, the Company's cash, cash equivalents, short-term investments and deposits amounted to $496 million compared to $442 million as of December 31, 2024. In addition, the Company maintained about $1.1 billion of unused credit facilities, as of December 31, 2025.

    Outstanding net debt

    As of December 31, 2025, ICL's net financial liabilities amounted to $2,260 million, an increase of $409 million compared to December 31, 2024. In addition, as of December 31, 2025, the fair value balance of currency and interest rate swap transactions (CCS) economically reduces our finance liabilities by approximately $51 million.

    Debentures

    In December 2025, the Company repaid NIS 33 million (approximately $10 million) of Series G debentures, as scheduled.

    Subsequent to date of the report, in January 2026, the Company repaid a $46 million private placement bond, as scheduled.

    Credit facilities

    Sustainability-linked Revolving Credit Facility (RCF)

    As of December 31, 2025, the Company had utilized about $497 million of its $1,550 million credit facility framework.

    Securitization

    In December 2025, the Company signed a new securitization agreement with four international banks for a committed amount of $350 million and an additional uncommitted $100 million, maturing in December 2030. This agreement replaces the prior securitization facility, which recently matured, and includes slightly improved terms compared to the previous agreement. As of December 31, 2025, ICL had utilized approximately $325 million of the facility.

    Ratings and financial covenants

    Fitch Ratings

    In May 2025, Fitch Ratings reaffirmed the Company's long-term issuer default rating and senior unsecured rating at 'BBB-'. The outlook on the long-term issuer default rating is stable.

    S&P Ratings

    In July 2025, the S&P credit rating agency reaffirmed the Company's international credit rating and senior unsecured rating of 'BBB-' with a stable rating outlook. In addition, the S&P Maalot credit rating agency reaffirmed the Company's credit rating of 'ilAA' with a stable rating outlook.

    Financial covenants

    As of December 31, 2025, the Company was in compliance with all of the financial covenants stipulated in its financing agreements.

    Dividend Distribution

    In connection with ICL's fourth quarter 2025 results, the Board of Directors declared a dividend of 4.65 cents per share, or approximately $60 million. The dividend will be paid on March 25, 2026. The record date is March 10, 2026.

    About ICL

    ICL Group Ltd. is a global leader in agriculture, food and industrial solutions, utilizing its unique mineral resources and extensive expertise to address key sustainability challenges related to food security and access to essential minerals. ICL is focused on driving long-term growth through its specialty agriculture and food businesses, while strategically managing its bromine, potash, and phosphate mineral resources. ICL's global professional workforce is dedicated to expanding its growth engines and efficiently operating – both structurally and economically – while maintaining and optimizing its core operations. The Company's operations are organized under four segments: Industrial Products (Bromine), Potash, Phosphate Solutions and Growing Solutions.

    We disclose in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Our management uses adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below. Some of these items may recur. We calculate our adjusted net income attributable to the Company's shareholders by adjusting our net income attributable to the Company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below, excluding the total tax impact of such adjustments. We calculate our diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Our adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under "Consolidated adjusted EBITDA, and diluted adjusted Earnings Per Share for the periods of activity" below, which were adjusted for in calculating the adjusted operating income.

    You should not view adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the Company's shareholders determined in accordance with IFRS, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of our non-IFRS financial measures as tools for comparison. However, we believe adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management and investors by excluding certain items that management believes are not indicative of our ongoing operations. Our management uses these non-IFRS measures to evaluate the Company's business strategies and management performance. We believe that these non-IFRS measures provide useful information to investors because they improve the comparability of our financial results between periods and provide for greater transparency of key measures used to evaluate our performance.

    (1a) The Company only provides guidance on a non-GAAP basis. The Company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The Company provides guidance for consolidated adjusted EBITDA and for its Potash business the company provides sales volumes guidance. The Company believes this information provides greater transparency, as the price of potash has stabilized over the past few years and consolidated adjusted EBITDA is now a more relevant metric for investors to evaluate the company's performance and compare its financial results between periods.

    We present a discussion in the period-to-period comparisons of the primary drivers of change in the Company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on our businesses. We have based the following discussion on our financial statements. You should read such discussion together with our financial statements.

    Adjustments to Reported Operating and Net income (non-GAAP)

     

    10-12/2025

    10-12/2024

    1-12/2025

    1-12/2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Operating income (loss)

    (16)

    147

    580

    775

    Charges related to the security situation in Israel (1)

    18

    17

    54

    57

    Impairment and write-off of assets and provision for site closure (2)

    122

    20

    131

    35

    Provision for early retirement (3)

    19

    4

    28

    4

    Legal proceedings (4)

    80

    2

    80

    2

    Total adjustments to operating income

    239

    43

    293

    98

    Adjusted operating income

    223

    190

    873

    873

    Net income (loss) attributable to the shareholders of the Company

    (73)

    70

    226

    407

    Total adjustments to operating income

    239

    43

    293

    98

    Total tax adjustments (5)

    (45)

    (9)

    (54)

    (21)

    Total adjusted net income - shareholders of the Company

    121

    104

    465

    484

    (1)

    For 2025 and 2024, reflects charges relating to the security situation in Israel.

    (2)

    For 2025, reflects mainly asset write-offs resulting from the closure of LFP projects, impairment of assets in the Company's UK operation, and a small R&D activity in Israel, following the implementation of the Company's strategy, including efficiency and cost-reduction programs. It also includes asset write-offs related to a fire at Ashdod Port and two portfolio companies due to failed business continuity and funding. For 2024, reflects mainly a write-off of assets resulting from the closure of small sites in Israel and Turkey.

    (3)

    For 2025 and 2024, reflects provisions for early retirement due to restructuring at certain sites, as part of the Company's global efficiency plan.

    (4)

    For 2025, reflects a provision for prior years following a Supreme Court ruling regarding water extraction fees in the Dead Sea concession area. For 2024, reflects reimbursement of arbitration costs associated with the Ethiopian potash project. 

    (5)

    For 2025 and 2024, reflects the tax impact of adjustments made to operating income. 

     
     

    Consolidated adjusted EBITDA and diluted adjusted Earnings Per Share for the periods of activity

    Calculation of adjusted EBITDA was made as follows:

     

    10-12/2025

    10-12/2024

    1-12/2025

    1-12/2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Net income (loss)

    (63)

    81

    280

    464

    Financing expenses, net

    45

    33

    139

    140

    Taxes on income

    2

    33

    161

    172

    Less: Share in earnings of equity-accounted investees

    -

    -

    -

    (1)

    Operating income (loss)

    (16)

    147

    580

    775

    Depreciation and amortization

    157

    157

    615

    596

    Adjustments (1)

    239

    43

    293

    98

    Total adjusted EBITDA

    380

    347

    1,488

    1,469

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" above.

     
     

    Calculation of diluted adjusted earnings per share was made as follows:

     

    10-12/2025

    10-12/2024

    1-12/2025

    1-12/2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Net income (loss) attributable to the Company's shareholders

    (73)

    70

    226

    407

    Adjustments (1)

    239

    43

    293

    98

    Total tax adjustments

    (45)

    (9)

    (54)

    (21)

    Adjusted net income - shareholders of the Company

    121

    104

    465

    484

    Weighted-average number of diluted ordinary shares outstanding (in thousands)

    1,290,669

    1,290,330

    1,291,395

    1,290,039

    Diluted adjusted earnings per share (in dollars) (2)

    0.09

    0.08

    0.36

    0.38

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" above.

    (2)

    The diluted adjusted earnings per share is calculated by dividing the adjusted net income‑shareholders of the Company by the weighted-average number of diluted ordinary shares outstanding (in thousands).

     
     

    Consolidated Results Analysis

    Results analysis for the period October – December 2025

     

    Sales

    Expenses

    Operating income

     

    $ millions

    Q4 2024 figures

    1,601

    (1,454)

    147

    Total adjustments Q4 2024*

    -

    43

    43

    Adjusted Q4 2024 figures

    1,601

    (1,411)

    190

    Quantity

    (49)

    36

    (13)

    Price

    98

    -

    98

    Exchange rates

    51

    (72)

    (21)

    Raw materials

    -

    (39)

    (39)

    Energy

    -

    (3)

    (3)

    Transportation

    -

    3

    3

    Operating and other expenses

    -

    8

    8

    Adjusted Q4 2025 figures

    1,701

    (1,478)

    223

    Total adjustments Q4 2025*

    -

    (239)

    (239)

    Q4 2025 figures

    1,701

    (1,717)

    (16)

    *

    See "Adjustments to reported Operating and Net income (non-GAAP)" above.

    • Quantity – The negative impact on operating income was due to lower sales volumes of potash, magnesium, phosphate fertilizers and FertilizerpluS products. This was partially offset by higher sales volumes of white phosphoric acid (WPA) and food specialties.
    • Price – The positive impact on operating income was primarily related to an increase of $63 in the potash price (CIF) per tonne, as well as higher selling prices for bromine-based industrial solutions, bromine-based flame retardants, phosphate fertilizers, specialty agriculture products and FertilizerpluS products. This was partially offset by lower selling prices for food specialties.
    • Exchange rates – The unfavorable impact on operating income was mainly due to higher operational costs resulting from the appreciation of the average exchange rate of the euro, the Israeli shekel and the Brazilian real against the US dollar, which outweighed the positive impact on sales from the appreciation of the average exchange rate of the euro and the Brazilian real against the US dollar.
    • Raw materials – The negative impact on operating income was due to higher costs of sulphur, commodity fertilizers and nitrogen. This was partially offset by lower costs of ammonia.
    • Operating and other expenses – The positive impact on operating income was primarily related to lower operational costs.

    Security situation in Israel

    In October 2023, the Israeli government declared a state of war in response to attacks on its civilians in the southern region of the country, which subsequently escalated to other areas. On October 9, 2025, Israel signed a ceasefire agreement. The security situation over the past two years has created several challenges, including disruptions to supply chains and shipping routes, personnel shortages due to recurring rounds of mobilization for reserve duty, additional costs to protect Company sites/assets, effects of reluctance to perform contractual obligations in Israel during hostilities, various bans and limitations on trade and cooperation with Israel related entities, and fluctuations in foreign currency exchange rates relative to the Israeli shekel. Additionally, ongoing regional tensions – including Houthis threats to commercial vessels – continue to disrupt shipping routes and commercial shipping arrangements, leading to increased shipping costs.

    We continue to take measures to ensure the safety of our employees and business partners, as well as the communities in which we operate. We have also implemented supportive measures to accommodate those of our employees who are called for reserve duty, aiming to minimize any potential impact on our business, and to avoid disruptions to production activities at our facilities in Israel.

    We continuously monitor developments and will take all necessary actions to minimize any negative consequences to our operations and assets. As of the reporting date, the security situation has not had a material impact on our business results. However, its future effects remain uncertain due to the unpredictable nature and duration of the conflict.

    Forward-looking Statements

    This announcement contains statements that constitute "forward‑looking statements", many of which can be identified by the use of forward‑looking words such as "anticipate", "believe", "could", "expect", "should", "plan", "intend", "estimate", "strive", "forecast", "targets" and "potential", among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements.

    Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding the Company's intent, belief or current expectations. Forward‑looking statements are based on management's beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:

    Changes in exchange rates or prices compared to those we are currently experiencing; the effects of the ongoing security situation in Israel, including the nature and duration of related conflicts; loss or impairment of business licenses or mineral extractions permits or concessions, including our ability to win the new concession at the Dead Sea in 2030 ; volatility of supply and demand and the impact of competition; the difference between actual reserves and the Company reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at the Company's seaport shipping facilities or regulatory restrictions affecting the Company's ability to export products overseas; general market, political or economic conditions in the countries in which the Company operates, including tariffs and trade policies; price increases or shortages with respect to the Company's principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the Company plants; labor disputes, slowdowns and strikes involving the Company employees; pension and health insurance liabilities; disruptions from pandemics that may impact the Company sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in the Company evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of the Company, or the Company service providers', information technology systems or breaches of the company, or the Company service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the Company cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the Company's businesses; changes in demand for the Company's fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company control; sales of the company magnesium products being affected by various factors that are not within the Company control; the Company ability to secure approvals and permits from the authorities in Israel to continue the Company's phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the Company's workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of security tension in Israel and the resulting disruptions to the Company supply and production chains; filing of class actions and derivative actions against the Company, its executives and Board members; the Company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the Company's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the US Securities and Exchange Commission (the "SEC") on March 13, 2025 (the "Annual Report").

    Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risks and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements.

    This announcement for the fourth quarter of 2025 (the "Quarterly Report") should be read in conjunction with the Annual Report and the report for the first, second and third quarters of 2025 published by the Company (the "prior quarterly reports"), including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the US SEC.

    Appendix:

    Condensed Consolidated Statements of Financial Position as of (Unaudited)

     

    December 31,

    2025

    December 31,

    2024

     

    $ millions

    $ millions

    Current assets

     

     

    Cash and cash equivalents

    291

    327

    Short-term investments and deposits

    205

    115

    Trade receivables

    1,365

    1,260

    Inventories

    1,934

    1,626

    Prepaid expenses and other receivables

    369

    258

    Total current assets

    4,164

    3,586

     

     

     

    Non-current assets

     

     

    Deferred tax assets

    180

    143

    Property, plant and equipment

    6,785

    6,462

    Intangible assets

    955

    869

    Other non-current assets

    329

    261

    Total non-current assets

    8,249

    7,735

     

     

     

    Total assets

    12,413

    11,321

     

     

     

    Current liabilities

     

     

    Short-term debt

    876

    384

    Trade payables

    1,157

    1,002

    Provisions

    58

    63

    Other payables

    1,040

    867

    Total current liabilities

    3,131

    2,316

     

     

     

    Non-current liabilities

     

     

    Long-term debt and debentures

    1,880

    1,909

    Deferred tax liabilities

    502

    481

    Long-term employee liabilities

    390

    331

    Long-term provisions and accruals

    231

    242

    Other

    36

    55

    Total non-current liabilities

    3,039

    3,018

     

     

     

    Total liabilities

    6,170

    5,334

     

     

     

    Equity

     

     

    Total shareholders' equity

    5,983

    5,724

    Non-controlling interests

    260

    263

    Total equity

    6,243

    5,987

     

     

     

    Total liabilities and equity

    12,413

    11,321

     
     
     

    Condensed Consolidated Statements of Income (Unaudited)

    (In millions except per share data)

     

    For the three-month

    period ended

    December 31

    For the year ended

    December 31

     

    2025

    2024

    2025

    2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Sales

    1,701

    1,601

    7,153

    6,841

    Cost of sales

    1,233

    1,066

    4,967

    4,585

     

     

     

     

     

    Gross profit

    468

    535

    2,186

    2,256

     

     

     

     

     

    Selling, transport and marketing expenses

    286

    281

    1,114

    1,114

    General and administrative expenses

    73

    68

    299

    259

    Research and development expenses

    17

    19

    70

    69

    Other expenses

    131

    33

    161

    60

    Other income

    (23)

    (13)

    (38)

    (21)

     

     

     

     

     

    Operating income (loss)

    (16)

    147

    580

    775

     

     

     

     

     

    Finance expenses

    93

    71

    298

    181

    Finance income

    (48)

    (38)

    (159)

    (41)

    Finance expenses, net

    45

    33

    139

    140

     

     

     

     

     

    Share in earnings of equity-accounted investees

    -

    -

    -

    1

     

     

     

     

     

    Income (loss) before taxes on income

    (61)

    114

    441

    636

     

     

     

     

     

    Taxes on income

    2

    33

    161

    172

     

     

     

     

     

    Net income (loss)

    (63)

    81

    280

    464

     

     

     

     

     

    Net income attributable to non-controlling interests

    10

    11

    54

    57

     

     

     

     

     

    Net income (loss) attributable to shareholders of the Company

    (73)

    70

    226

    407

     

     

     

     

     

    Earnings per share attributable to shareholders of the Company:

     

     

     

     

     

     

     

     

     

    Basic earnings per share (in dollars)

    (0.06)

    0.06

    0.18

    0.32

     

     

     

     

     

    Diluted earnings per share (in dollars)

    (0.06)

    0.06

    0.18

    0.32

     

     

     

     

     

    Weighted-average number of ordinary shares outstanding:

     

     

     

     

     

     

     

     

     

    Basic (in thousands)

    1,290,669

    1,290,260

    1,290,580

    1,289,968

     

     

     

     

     

    Diluted (in thousands)

    1,290,669

    1,290,330

    1,291,395

    1,290,039

     
     
     

    Condensed Consolidated Statements of Cash Flows (Unaudited)

     

    For the three-month

    period ended

    For the year ended

     

    December 31, 2025

    December 31, 2024

    December 31, 2025

    December 31, 2024

     

    $ millions

    $ millions

    $ millions

    $ millions

    Cash flows from operating activities

     

     

     

     

    Net income (loss)

    (63)

    81

    280

    464

    Adjustments for:

     

     

     

     

    Depreciation and amortization

    157

    157

    615

    596

    Fixed assets impairment

    111

    7

    111

    14

    Exchange rate, interest and derivative, net

    27

    47

    59

    152

    Tax expenses

    2

    33

    161

    172

    Change in provisions

    31

    3

    26

    (50)

    Other

    4

    7

    18

    13

     

    332

    254

    990

    897

     

     

     

     

     

    Change in inventories

    (145)

    (102)

    (210)

    (7)

    Change in trade receivables

    45

    68

    (11)

    26

    Change in trade payables

    110

    87

    100

    104

    Change in other receivables

    1

    66

    (22)

    39

    Change in other payables

    71

    39

    80

    43

    Net change in operating assets and liabilities

    82

    158

    (63)

    205

     

     

     

     

     

    Income taxes paid, net of refund

    (37)

    (41)

    (151)

    (98)

     

     

     

     

     

    Net cash provided by operating activities

    314

    452

    1,056

    1,468

     

     

     

     

     

    Cash flows from investing activities

     

     

     

     

    Proceeds (payments) from deposits, net

    (82)

    (5)

    (86)

    56

    Purchases of property, plant and equipment and intangible assets

    (252)

    (267)

    (824)

    (713)

    Proceeds (payments) from divestiture of assets and businesses, net of transaction expenses

    (3)

    -

    1

    19

    Proceeds (payments) from settlement of derivatives, net

    1

    -

    (9)

    -

    Interest received

    3

    3

    15

    17

    Business combinations

    -

    (2)

    (12)

    (74)

    Other

    -

    1

    -

    1

    Net cash used in investing activities

    (333)

    (270)

    (915)

    (694)

     

     

     

     

     

    Cash flows from financing activities

     

     

     

     

    Dividends paid to the Company's shareholders

    (62)

    (68)

    (224)

    (251)

    Receipts of long-term debt

    152

    278

    1,666

    889

    Repayments of long-term debt

    (183)

    (383)

    (1,599)

    (1,302)

    Receipts (repayments) of short-term debt, net

    92

    (8)

    146

    (1)

    Interest paid

    (43)

    (43)

    (117)

    (122)

    Payments from transactions in derivatives

    (1)

    (3)

    (3)

    (2)

    Dividend paid to the non-controlling interests

    -

    -

    (64)

    (57)

    Net cash used in financing activities

    (45)

    (227)

    (195)

    (846)

     

     

     

     

     

    Net change in cash and cash equivalents

    (64)

    (45)

    (54)

    (72)

    Cash and cash equivalents as of the beginning of the period

    356

    393

    327

    420

    Net effect of currency translation on cash and cash equivalents

    (1)

    (21)

    18

    (21)

    Cash and cash equivalents as of the end of the period

    291

    327

    291

    327

     
     
     

    Operating segment data

    Industrial

    Products

    Potash

    Phosphate

    Solutions

    Growing

    Solutions

    Other

    Activities

    Reconciliations

    Consolidated 

    $ millions

    For the three-month period ended December 31, 2025

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Sales to external parties

    294

    427

    471

    465

    44

    -

    1,701

    Inter-segment sales

    2

    46

    47

    2

    1

    (98)

    -

    Total sales

    296

    473

    518

    467

    45

    (98)

    1,701

     

     

     

     

     

     

     

     

    Cost of sales

    195

    310

    360

    333

    46

    (11)

    1,233

    Segment operating income (loss)

    52

    86

    76

    41

    (8)

    (24)

    223

    Other expenses not allocated to the segments

     

     

     

     

     

     

    (239)

    Operating income (loss)

     

     

     

     

     

     

    (16)

     

     

     

     

     

     

     

     

    Financing expenses, net

     

     

     

     

     

     

    (45)

     

     

     

     

     

     

     

     

    Income (loss) before income taxes

     

     

     

     

     

     

    (61)

     

     

     

     

     

     

     

     

    Depreciation, amortization and impairment

    16

    64

    45

    19

    5

    119

    268

    Capital expenditures

    28

    124

    94

    41

    6

    17

    310

     

     

     

     

     

     

     

     

     
     
     

    Operating segment data (cont'd)

    Industrial

    Products

    Potash

    Phosphate

    Solutions

    Growing

    Solutions

    Other

    Activities

    Reconciliations

    Consolidated 

    $ millions

    For the three-month period ended December 31, 2024

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Sales to external parties

    275

    373

    475

    435

    43

    -

    1,601

    Inter-segment sales

    5

    49

    32

    4

    -

    (90)

    -

    Total sales

    280

    422

    507

    439

    43

    (90)

    1,601

     

     

     

     

     

     

     

     

    Cost of sales

    177

    260

    344

    313

    44

    (72)

    1,066

    Segment operating income (loss)

    55

    69

    81

    31

    (8)

    (38)

    190

    Other expenses not allocated to the segments

     

     

     

     

     

     

    (43)

    Operating income

     

     

     

     

     

     

    147

     

     

     

     

     

     

     

     

    Financing expenses, net

     

     

     

     

     

     

    (33)

     

     

     

     

     

     

     

     

    Income before income taxes

     

     

     

     

     

     

    114

     

     

     

     

     

     

     

     

    Depreciation, amortization and impairment

    15

    61

    51

    20

    4

    13

    164

    Capital expenditures

    38

    116

    147

    44

    3

    12

    360

    Capital expenditures as part of business combination

    -

    -

    -

    4

    -

    -

    4

     
     
     

    Information based on geographical location

    The following table presents the distribution of the operating segments sales by geographical location of the customer:

     

    10-12/2025

    10-12/2024

     

    $

    millions

    % of

    sales

    $

    millions

    % of

    sales

    China

    337

    20

    274

    17

    Brazil

    315

    19

    276

    17

    USA

    281

    17

    280

    17

    Israel

    82

    5

    69

    4

    India

    80

    5

    64

    4

    Spain

    77

    5

    73

    5

    United Kingdom

    70

    4

    58

    4

    Germany

    61

    4

    65

    4

    France

    57

    3

    48

    3

    Austria

    35

    2

    32

    2

    All other

    306

    16

    362

    23

    Total

    1,701

    100

    1,601

    100

     
     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260217956054/en/

    Investor and Press Contact – Global

    Peggy Reilly Tharp

    VP, Global Investor Relations

    +1-314-983-7665

    [email protected]

    Investor and Press Contact - Israel

    Adi Bajayo

    VP, ICL Spokesperson and Israel IR

    +972-3-6844459

    [email protected]

    Get the next $ICL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ICL

    DatePrice TargetRatingAnalyst
    1/21/2025$4.00 → $6.00Underweight → Equal Weight
    Barclays
    1/12/2024$6.50 → $4.00Overweight → Underweight
    Barclays
    11/14/2023$7.00 → $6.50Equal Weight → Overweight
    Barclays
    5/18/2023Buy → Neutral
    BofA Securities
    6/1/2022$12.00Equal Weight
    Barclays
    2/14/2022$9.00 → $10.00Equal-Weight
    Morgan Stanley
    12/6/2021$7.00 → $9.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ICL
    SEC Filings

    View All

    SEC Form 6-K filed by ICL Group Ltd.

    6-K - ICL Group Ltd. (0000941221) (Filer)

    2/18/26 6:05:17 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by ICL Group Ltd.

    6-K - ICL Group Ltd. (0000941221) (Filer)

    2/18/26 6:00:54 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by ICL Group Ltd.

    6-K - ICL Group Ltd. (0000941221) (Filer)

    2/18/26 6:03:05 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    ICL Group upgraded by Barclays with a new price target

    Barclays upgraded ICL Group from Underweight to Equal Weight and set a new price target of $6.00 from $4.00 previously

    1/21/25 7:50:33 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Group downgraded by Barclays with a new price target

    Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously

    1/12/24 6:56:19 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Group upgraded by Barclays with a new price target

    Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously

    11/14/23 7:37:49 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ICL Reports Fourth Quarter and Full Year 2025 Results

    Annual sales increase 5% to $7,153 million, with adjusted EBITDA of $1,488 million and earnings per share of $0.36 Company advances strategic principles, with acquisition of Bartek Ingredients and review of non-core assets ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, consolidated sales of $1,701 million were up 6% versus $1,601 million in the fourth quarter of 2024. Operating income was ($16) million versus $147 million, while adjusted operating income of $223 million was up 17% versus $190 million in 2024. Adjusted EBITDA of $380 million

    2/18/26 2:15:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Announces Fourth Quarter 2025 Earnings Call

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release fourth quarter 2025 results prior to the opening of the TASE market on Wednesday, February 18, 2026. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (289) 819-1520 for international analysts, and the conference ID is 71097. To participate, please dial in a few minutes before the scheduled time.

    1/29/26 8:30:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Group Expands Further into Global Food Ingredients with Acquisition of Bartek Ingredients

    Company executing against new strategic principles, to drive sustainable and profitable growth ICL (NYSE:ICL) (TASE: ICL) today announced it has entered into a definitive agreement to acquire Bartek Ingredients. Bartek is the global leader in food-grade malic and fumaric acid and serves hundreds of customers and distributors in the food, beverage, confectionery, bakery and other end-markets worldwide. These functional food ingredients are used by food and beverage companies to enhance flavor profiles, extend shelf life and improve overall quality. These additives also contribute to the quality, safety and efficacy of personal care products. Bartek distributes its products to more than 40

    12/18/25 1:30:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Financials

    Live finance-specific insights

    View All

    ICL Reports Fourth Quarter and Full Year 2025 Results

    Annual sales increase 5% to $7,153 million, with adjusted EBITDA of $1,488 million and earnings per share of $0.36 Company advances strategic principles, with acquisition of Bartek Ingredients and review of non-core assets ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, consolidated sales of $1,701 million were up 6% versus $1,601 million in the fourth quarter of 2024. Operating income was ($16) million versus $147 million, while adjusted operating income of $223 million was up 17% versus $190 million in 2024. Adjusted EBITDA of $380 million

    2/18/26 2:15:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Announces Fourth Quarter 2025 Earnings Call

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release fourth quarter 2025 results prior to the opening of the TASE market on Wednesday, February 18, 2026. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (289) 819-1520 for international analysts, and the conference ID is 71097. To participate, please dial in a few minutes before the scheduled time.

    1/29/26 8:30:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Reports Third Quarter 2025 Results and Announces New Strategic Principles

    Renewed focus on driving profitable growth engines in its specialty businesses Maximizing and improving its potash, phosphate and bromine mineral businesses Driving overall portfolio optimization and cost efficiency across all activities ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, 2025. Consolidated sales were $1.9 billion, up $100 million versus the prior year. Operating income was $230 million versus $214 million in the third quarter of last year, with adjusted operating income of $241 million versus $243 million. For the third quarter, net income attributable to shareholders

    11/12/25 2:17:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Leadership Updates

    Live Leadership Updates

    View All

    ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced its Board of Directors has approved the appointment of Elad Aharonson as ICL's new president and chief executive officer, effective March 13, 2025. He will succeed Raviv Zoller who will work with Aharonson to ensure a smooth and orderly transition. Elad Aharonson has been an integral part of ICL for nearly four years, serving as president of ICL's Growing Solutions business since April of 2021. During his tenure, he led the development of ICL's specialty fertilizer solutions and the expansion of these product offerings into new territories, through both organic efforts and via acquisitions. His signif

    12/23/24 2:10:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Announces Planned Departure of President and CEO Raviv Zoller

    Zoller to continue to serve the company until a replacement has been announced ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Raviv Zoller, the company's president and CEO for the past seven years, is expected to leave the company in early 2025, following both the appointment of a replacement and a formal transition. In a letter to the company's employees, Zoller wrote, "I feel great pride, mixed with sorrow, as I announce my expected retirement from the position as president and CEO of ICL. Over the past seven years at this amazing organization, I have come to know our employees who give their heart and soul to the company. Together, we ha

    12/5/24 7:21:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Recognized by Fortune as a Company That is Changing the World

    Company's Agmatix AI-driven data platform and RegenIQ framework designated as a Friend of Farmers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Agmatix, the company's ag tech digital start-up, has been named to Fortune's 10th Annual Change the World list. The list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Among other factors, nominees are assessed on their measurable impact on people and the planet, profitability related to their impactful work, and the degree of innovation they have demonstrated. Agmatix was recognized for its AI-driven platform, which helps

    10/15/24 4:15:00 PM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ICL Group Ltd.

    SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

    11/14/24 6:11:02 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by ICL Group Ltd.

    SC 13G - ICL Group Ltd. (0000941221) (Subject)

    1/31/24 6:05:59 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G/A filed by ICL Group Ltd. (Amendment)

    SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

    1/30/24 8:10:40 AM ET
    $ICL
    Agricultural Chemicals
    Industrials